Kallo, Inc. (OTCQB: KALO) develops and delivers innovative, technologically advanced and turnkey healthcare solutions in the developing world and rural communities including infectious disease management, education and training programs. The company's mobile technology suite transforms the delivery of rural medicine, disease management, clinical globalization, and eHealth solutions.
KALO was recognized last month with the Frost & Sullivan 2015 Award for Emerging Market Innovation. This award recognizes Kallo's unique holistic approach to healthcare delivery. Kallo's modular approach caters to the specific healthcare needs of each region through a combination of polyclinics, mobile clinics, teaching institutions and telemedicine. This system is designed to serve such emerging nations as Guinea, Senegal, Nigeria, Peru, Brazil, Cameroon and Chad.